Quest Diagnostics Incorporated
DGXFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
9,872
Cost of Revenue
6,628
Gross Profit
3,244
Gross Margin
32.9%
Operating Income
1,346
Operating Margin
13.6%
Net Income
871
Net Margin
8.8%
EPS (Basic)
$7.80
EPS (Diluted)
$7.69
EBITDA
1,894
EBITDA Margin
19.2%
2023
12/31/2023
Revenue
9,252
Cost of Revenue
6,199
Gross Profit
3,069
Gross Margin
33.2%
Operating Income
1,262
Operating Margin
13.6%
Net Income
854
Net Margin
9.2%
EPS (Basic)
$7.59
EPS (Diluted)
$7.52
EBITDA
1,732
EBITDA Margin
18.7%
2022
12/31/2022
Revenue
9,883
Cost of Revenue
6,450
Gross Profit
3,433
Gross Margin
34.7%
Operating Income
1,428
Operating Margin
14.4%
Net Income
946
Net Margin
9.6%
EPS (Basic)
$8.12
EPS (Diluted)
$7.98
EBITDA
1,820
EBITDA Margin
18.4%
2021
12/31/2021
Revenue
10,788
Cost of Revenue
6,579
Gross Profit
4,209
Gross Margin
39.0%
Operating Income
2,381
Operating Margin
22.1%
Net Income
1,995
Net Margin
18.5%
EPS (Basic)
$15.90
EPS (Diluted)
$15.53
EBITDA
3,159
EBITDA Margin
29.3%
2020
12/31/2020
Revenue
9,437
Cost of Revenue
5,804
Gross Profit
3,633
Gross Margin
38.5%
Operating Income
1,971
Operating Margin
20.9%
Net Income
1,431
Net Margin
15.2%
EPS (Basic)
$10.68
EPS (Diluted)
$10.52
EBITDA
2,411
EBITDA Margin
25.5%